← brief for 2026-08-13 · Regeneration & devices

Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles as Antifibrotic Nanotherapeutics for Chronic Kidney Disease.

Article D Peer reviewed Preclinical

Key takeaways

This study uses engineered stem cell-derived vesicles to treat kidney fibrosis (scarring). These are not human trials: this was done in mice and organoids.

Who did this work

Zhang W · Xu S · Cao Z · Jin W · Deng S · Zhou Q · Xia X · Wang X

Source

Article · PubMed, fibrosis reversal · 2026 Aug 11
https://pubmed.ncbi.nlm.nih.gov/42581571/